-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Real-World Applications of Asparaginase Formulations in ALL and LBL from Pediatric/AYA to Adult Treatment: Maximizing Clinical Benefits Through Multidisciplinary Care

Sponsor: Jazz Pharmaceuticals, Inc. and Servier Pharmaceuticals
Program: Friday Satellite Symposia
Hematology Disease Topics & Pathways:
Research, Clinical Practice (Health Services and Quality), Diseases, Therapies, Adverse Events, Biological Processes
Friday, December 8, 2023: 3:00 PM-6:00 PM
Room 6A (San Diego Convention Center)
Rachel E. Rau, MD, Texas Children's Hospital/Baylor College of Medicine
Rau: Jazz: Consultancy, Membership on an entity's Board of Directors or advisory committees; Takeda: Speakers Bureau; AbbVie: Other: Husband paid employee.
Luke Maese, DO, Huntsman Cancer Institute, University of Utah , Etan Orgel, MD, Keck School of Medicine of USC and Lauren Huang, DNP, ARNP, PNP-PC, Seattle Children's Hospital
Maese: Jazz Pharmaceuticals: Consultancy, Speakers Bureau. Orgel: Jazz Pharmaceuticals, SeaGen Inc.: Consultancy.
Access Program Details

The live activity will feature a series of didactic presentations coupled with case-based panel discussions and question-and-answer sessions from the audience. Using a blended instructional model of didactic presentations and interactive panel discussions is intended is to improve medical practices and patient care through evidence-based presentations, discussion, and authoritative peer-exchange on important clinical issues. The satellite program will bring together 4 clinical experts to highlight novel agents in the management of ALL/LBL, including the latest clinical data and application of asparaginase formulations across the ALL continuum, including best practices for monitoring and managing hypersensitivity and silent inactivation reactions in the United States and around the world! Considerations for advanced practice professionals and community clinicians will also be addressed throughout the educational event.